Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in Progressive Multiple Sclerosis
NCT01144117Phase 2Unknown
- Sponsor
- Rigshospitalet
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin beta in primary progressive multiple sclerosis (PPMS), secondary-progressive multiple sclerosis (SPMS), sponsored by Rigshospitalet. Status: unknown.
02
Drugs
epoetin beta
03
Conditions
primary progressive multiple sclerosis (PPMS)secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT01144117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01144117.